Jim Cramer: How Long Will the Bear Market in Biotech Continue?

TheStreet's Action Alerts PLUS Portfolio Manager Jim Cramer isn't too fond of Eli Lilly (LLY) - Get Report . 'Lilly is a little disappointing - we had to sell it for Action Alerts PLUS,' Cramer said. 'The fabulous things we were hoping for with Alzheimer's are not coming true.' He said drug companies are public enemy number one.

At the time of publication, Jim Cramer's charitable trust Action Alerts PLUS held no positions in stocks mentioned.